Immaculata De Vivo, PhD, MPH, is the Melanie Mason Niemiec ’71 Faculty Codirector of the Sciences at the Harvard Radcliffe Institute, Professor of Medicine at Harvard Medical School, and Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. She is an internationally recognized leader in the molecular and genetic epidemiology of cancer. De Vivo’s research integrates molecular biology, genetics, and epidemiology to elucidate how inherited and acquired variation—particularly in hormonal pathways and telomere biology—contributes to cancer susceptibility and other chronic diseases. She has led pioneering work on genetic determinants of endometrial cancer, telomere length and chronic disease, and gene–environment interactions using large, well‑characterized cohorts. She is the author of over 340 peer‑reviewed scientific publications.

For twenty years, De Vivo served as Scientific Director of the Dana-Farber/Harvard Cancer Center Genotyping and Genetics for Population Sciences Core facility. She is a co‑founder and executive leader of the international Epidemiology of Endometrial Cancer Consortium (E2C2). Her research has been continuously funded by the National Institutes of Health and the American Cancer Society, which honored her with an American Cancer Society Research Scholar Grant, among other national and international recognitions including NASA’s Human Research Program. She currently serves as Editor‑in‑Chief of Cancer Causes & Control